Tesla’s largest production base already builds a million cars a year. If its China president is right, the same plant could become the world’s first…
With its first 2nm AI GPU entering prototype verification, Dishan Technology signals that the next frontier of advanced chip design may no longer be the…
For global biotech and life sciences firms weighing an IPO in Asia, Hong Kong’s willingness to rewrite its listing rules signals a serious effort to…
A quiet strategic shift is redefining global AI competition: the real prize may not be building the most powerful model, but deploying it at scale…
As world models emerge as the next critical layer for physical AI, China’s advantage is no longer theoretical. The country’s deep integration of AI development…
As the global race for a Covid-19 cure accelerates, China’s biotechnology sector is experiencing a powerful wave of consolidation and capital inflows, signalling a strategic…
For global professionals tracking China’s strategic technological ascent, the return of a leading researcher from the United States signals a deepening shift in the geography…
As the race for next-generation AI infrastructure intensifies, silicon photonics is emerging from the shadows. A Chinese pioneer’s push toward a public listing signals that…
For global professionals tracking the convergence of advanced manufacturing and artificial intelligence, Shanghai is no longer just the world’s car capital—it is the laboratory where…
For global pharmaceutical and tech investors, the convergence of deep-pocketed AI giants and drug discovery marks a pivotal shift in how new therapies may be…
No products in the cart.
